EIN News: Benelux Biotech News

All together now

24 Jul 2008 18:33 GMT

... drugs business (see chart). IMS Health, an industry research firm, reckons that $130 billion of ... like those found in America, Britain, the Netherlands and Scandinavia, and coddled ones, like those ... pills based on chemistry, these mimic newer biotechnology drugs. The new generics giants have the ...

Benelux shares close lower; Umicore, TNT lead fallers UPDATE

24 Jul 2008 18:33 GMT

... BRUSSELS (Thomson Financial) - Benelux shares close lower, hit by Wall Street ... with speciality materials group Umicore and postal company TNT leading the blue-chip fallers. At the ... that its offer period for shares in biotech group Innogenetics will run from Aug. 12 ...

Solvay Pharmaceuticals S.A. Plans the Offer Period for Innogenetics from August 12 to September 5, 2008

24 Jul 2008 17:09 GMT

... period to acquire Innogenetics N.V., a Belgian-based biotechnological company, from August 12 to September 5, ... of companies that constitutes the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical ...

Benelux shares close lower; Umicore, TNT lead fallers

24 Jul 2008 17:08 GMT

... Benelux shares close lower; Umicore, TNT lead fallers ... that its offer period for shares in biotech group Innogenetics will run from Aug. 12 ... from 'hold' by Theodoor Gilissen after the company reported better-than-expected second quarter results Wednesday. Outside ...

Frankfurt Hosts Continuing Growth of CMPi Pharma Events

24 Jul 2008 16:14 GMT

... MAARSSEN, Netherlands, July 24 /PRNewswire/ -- The global pharma ... time that the city hosts CPhI. The industry has seen major growth since the event ... industry issues. ICSE will again feature the Biotech, IT, Clinical Trials and New Exhibitor "Zones", ...

Foster Wheeler Awarded Contract for Biomass CFB Steam Generator in Belgium

24 Jul 2008 13:31 GMT

... steam generator to be located in Oostrozebeke, Belgium. The new biomass-fired CFB will be owned ... and gas-to-liquids, refining, petrochemicals, chemicals, power, pharmaceuticals, biotechnology and healthcare industries. The company is based ... and the following, could cause the Company's business conditions and results to differ materially from ...

Delivers solid financial performance while building ...

24 Jul 2008 12:16 GMT

... of 2009. Approval of 4000L-scale production in Belgium will be necessary to meet the anticipated ... C-section procedures. Second-quarter revenue for the Genetics business increased 7 percent to $78.5 million from ... About Genzyme One of the world's leading biotechnology companies, Genzyme is dedicated to making a ...

Biogen Idec, Elan Celebrate Second Anniversary of TYSABRI for Treatment of Multiple Sclerosis

24 Jul 2008 12:14 GMT

... agencies in countries including Australia, Austria, the Netherlands, the United Kingdom, Sweden, France and Germany ... biogenidec.com. Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the ...

Genzyme Corporation Reports Strong Growth in Second Quarter 2008

24 Jul 2008 12:14 GMT

... of 2009. Approval of 4000L-scale production in Belgium will be necessary to meet the anticipated ... C-section procedures. Second-quarter revenue for the Genetics business increased 7 percent to $78.5 million from ... rights reserved. One of the world's leading biotechnology companies, Genzyme is dedicated to making a ...

DIARY - Western European Corporate Events - Part 2 UPDATE

24 Jul 2008 07:32 GMT

... Holding AG H1 06/Aug BE Wereldhave Belgium H1 06/Aug DK Ringkjoebing Landbobank A/S ... Data ASA Q2 06/Aug SE Active Biotech AB Q2 CTI.ST> 06/Aug SE Axfood AB ... AUM 06/Aug GB Foreign & Colonial Investment Trust H1 06/Aug GB Inmarsat plc ...

Trigen Appoints Dr. Ayad Abdul-Ahad as Chief Executive Officer and Dr. Norbert Bender as Chief Medical Officer

23 Jul 2008 16:18 GMT

... natalizumab (Tysabri) and Avonex, in addition to business development and medical marketing. Prior to this, ... Clinical Developments & Regulatory Affairs, SmithKline Beecham, Belgium, and Therapeutic Director Immunology & Oncology, Serono, ... Pharma Knoll), and from working for two biotech companies (Chief Medical Officer at Cardion, SVP ...

Genzyme Reports Strong Second-Quarter Growth

23 Jul 2008 12:50 GMT

Galapagos transfers predictive drug discovery databa...

23 Jul 2008 11:51 GMT

... makes software publicly available to researchers MECHELEN, Belgium Galapagos NV announces the transfer of ... discovery products and services to pharmaceutical and biotech companies, encompassing target discovery and validation, screening ... condition, performance or achievements of Galapagos, or industry results, to be materially different from any ...

Fluxome Sciences Expands Capital by DKK 100 mio /EUR 13 mio

23 Jul 2008 10:53 GMT

... 13 mio COPENHAGEN, Denmark, Jul 23, 2008 (BUSINESS WIRE) -- In a European biotech investment environment under pressure, fast-growing Danish biotech ... Cleantech Fund, managed by CAPRICORN Venture Partners (Belgium), to the group of share holders. "I ...

--> Galapagos transfers predictive drug discovery databases to EMBL's European Bioinformatics Institute

23 Jul 2008 06:30 GMT

... databases to EMBL's European Bioinformatics Institute MECHELEN, BELGIUM--(Marketwire - July 23, 2008) - Wellcome Trust ... discovery products and services to pharmaceutical and biotech companies, encompassing target discovery and validation, screening ... condition, performance or achievements of Galapagos, or industry results, to be materially different from any ...